• 대한소아치과학회지
• /
• 제35권4호
• /
• pp.737-743
• /
• 2008

국소적 치아 이형성증(Regional Odontodysplasia)은 치아 경조직에 비교적 드물게 나타나는 발육성 장애로 치열궁의 특정 사분악에 국한되어 나타나며 이환치 경조직의 모든 구성요소가 발육 부전이나 석회화 부전을 보인다. 국소적 치아 이형성증에 대한 장기적 치료와 관리를 위해서는 여러 분야에 걸친 체계적 접근이 요구되며, 치료 계획은 환자의 저작기능과 심미성의 회복, 정상적인 수직고경과 공간의 유지, 악골의 정상적인 성장과 이환치의 맹출관리를 도모할 목적으로 수립되어야 한다. 본 증례보고에서는 부산대학교병원 소아치과에서 국소적 치아 이형성증으로 진단받고, $2{\sim}5$년간 정기적인 관찰을 받아온 5세 8개월${\sim}$10세 9개월 어린이 3명을 대상으로 그 간의 치료 내용과 치아 발육과정을 검토해 보았다. 관찰 기간 동안 12개 이환치 중 심한 염증과 이형성으로 발거된 1개 치아를 제외한 모든 치아에서 석회화의 진행 또는 치조골 상방으로의 맹출성 이동을 보이긴 하였으나 그 정도와 속도는 개개 치아마다 매우 다양하였다. 그러므로 치료는 악골의 정상 발육과 공간 유지를 도모하고 치아의 조기 상실에 따른 부작용을 차단하기 위해서 이환치에 대하여 최대한으로 보존적인 접근을 하는 것이 추천된다. 또한 치아마다 그 발육정도가 다양하므로 개개 치아의 맹출 관리를 위한 독립적인 치료 계획을 수립하는 것이 바람직할 것으로 판단된다.

• Tuberculosis and Respiratory Diseases
• /
• 제70권3호
• /
• pp.206-217
• /
• 2011

Background: Transcription factor FOXP3 characterizes the thymically derived regulatory T cells. FOXP3 is expressed by cancer cell itself and FOXP3 expression was induced by TGF-${\beta}$ treatment in pancreatic cancer cell line. However, the expression of FOXP3 expression is not well known in patients with lung cancer. This study was conducted to investigate the expression of FOXP3 in patients with lung cancer and to investigate the regulation of FOXP3 expression by the treatment of TGF-${\beta}$ and DNA methyltransferase inhibitor in lung cancer cell lines. Methods: FOXP3 expression in the tissue of patients with resected non-small cell lung cancer (NSCLC) was evaluated by immunohistochemistry. The regulation of FOXP3 expression was investigated by Western blot and RT-PCR after lung cancer cell lines were stimulated with TGF-${\beta}1$ and TGF-${\beta}2$. The regulation of FOXP3 expression was also investigated by RT-PCR and flow cytometry after lung cancer cell lines were treated with DNA methyltransferase inhibitor (5-AZA-dC). Results: FOXP3 expression was confirmed in 27% of patients with NSCLC. In NCI-H460 cell line, TGF-${\beta}2$ decreased FOXP3 mRNA and protein expressions. In A549 cell line, both TGF-${\beta}1$ and TGF-${\beta}2$ decreased FOXP3 mRNA and protein expressions. 5-AZA-dC increased FOXP3 mRNA expression in NCI-H460 and A549 cell lines. Moreover, 5-AZA-dC increased intracellular FOXP3 protein expression in A549 cell lines. Conclusion: It was shown that FOXP3 is expressed by cancer cell itself in patients with NSCLC. Treatment of TGF-${\beta}2$ and DNA methyltransferase inhibitor seems to be associated with the regulation of FOXP3 expression in lung cancer cell lines.

• Journal of Periodontal and Implant Science
• /
• 제31권1호
• /
• pp.123-135
• /
• 2001

Several growth factors and polypeptides were studied for the regeneration of periodontal supporting tissues which had been lost due to periodontal disease. But these are not commonly used for regenerators of bone tissue or alveolar bone, because of the insufficiency of studies on their side effects, genetic engineering for mass production and stability for clinical application. Recently, many natural products, which have advantage of less side effects and possibility of long-term use, have been studied for their capacity and effects of anti-bacterial, anti-inflammatory and regenerative potential or periodontal tissues. Cnidii Rhizoma, Rhinocerotis Cornu and Drynariae Rhizoma have been traditionally used as a drug for treatment of bone disease in oriental medicine. The purpose of this study was to examine the ability of alkaline phosphatase synthesis of MC3T3-E1 cells when above medicines were supplimented. MC3T3-E1 cells were cultured with ${\alpha}-MEM(negative control)$, dexamethasone(positive control), and each natural products for 3 and 5 days. And then ALP synthesis was measured by spectrophotometer for enzyme activity and by naphthol AS-BI staining for morphometry. Except Cnidii Rhizoma, all of the natural products of this study induced higher activity of ALP synthesis than controls. Among them Drynariae Rhizoma induced the highest activity. In the aspects of culturing time, all medicines did not showed the difference between 3 and 5 days, but $10^{-7}g/ml$ group of Rhinocerotis Corun showed significant increase at 3 days than at 5 days. These results indicate that several natural products have a inducing ability of ALP synthesis on osteoblasts.

• Journal of Periodontal and Implant Science
• /
• 제34권1호
• /
• pp.49-59
• /
• 2004

The goal of periodontal treatment is not only to arrest the progression of the disease but also to promote the functional, esthetic regeneration of the periodontium. Flap operation, bone graft, guided tissue regeneration, growth factors and bone morphogenetic protein have been used for this purpose. Among these techniques of regeneration, alloplastic graft, especially calcium phosphate is getting more attention recently. The purpose of this study was to evaluate the effects of calcium phosphate glass on mouse calvarial cell in vitro. The toxicity of calcium phosphate glass was measured using MTT assay, the synthesis of collagen was measured using collagen assay, and ALP activity was measured. The experimental groups were cultured with calcium phosphate glass(both AQ-, and HT-CPG) in concentration of 0.01, 0.02, 0.1, 0.2g/ml. The results are as follows 1. In concentrations not exceeding 0.02g/ml, both the groups(AQ-CPG, HT-CPG) didn't show any toxicity on mouse calvarial cell(p<0.05). 2. In both the experimental groups are the concentration of 0.02g/ml, collagen expressions were significantly up-regulated (p<0.05). 3. In both the experimental groups are the concentration of 0.02g/ml, ALP activity was not significantly up-regulated, but ALP activity in both experimental groups were greater than control group(p<0.05). The results suggested that the use of calcium phosphate glass may promotes periodontal regeneration. Ongoing studies are necessary in order to determine their regeneration effects.

• Journal of Periodontal and Implant Science
• /
• 제25권3호
• /
• pp.478-486
• /
• 1995

Periodontal therapy for treatment of periodontitis involves the elimination of bacterial plaque and elimination of the anatomic defects by regenerative procedure. The purpose of this study was to evaluate on the biological effect of magnolia and Ginkgo biloba extract to the antimicrobial, antiinflammatory and cellular activity. Antimicrobial assay was performed with the diffusion method of the extract by measuring of growth inhibitory zone of B. cereus from blood agar plate. Effect of the extract to cellular activity of gingival fibroblast were examined using MTT method and measured the result with optical density on 570nm by ELISA reader. Inhibitory effects of $PGE_2$ production from gingival fibroblast was performed with the addition of $IL-l{\beta}$ and the extract to the well and examined to the product of $PGE_2$ from cell by ELISA reader. In vivo anti-inflammatory effect was performed with injection examined with clinically and histologically for their extent of mecrosis and inflammation. Antimicrobial activity of Magnolia extract showed significantly higher activity than that of control. However, GBE did not showed significant activity to compare with control, and mixture of Magnolia and GBE extract showed significantly higher activity than that of control. The effect of cellular activity to gingival fibroblast showed no significant differences of between control and Magnolia extract. However, GBE showed significantly higher rate of cellular activity to compare with control and even to PDGF-BB, and also showed same degree of cellular activity even though mixed with Magnolia extract. The inhibitory effect of $PGE_2$ production showed significantly reduction of $PGE_2$ production to compare with control, but its inhibitory effect was not much strong to compare with Indomethacin. In vivo, antiinflammatory effect of Magnolia extract to P. gingivalis injection of Hamster buccal check showed significantly reduction of inflammatory cell infiltration and tissue necrosis, but GBE showed no effect on the inhibition of inflammatory process. These results suggested that Magnolia and GBE extract possessed different kind of biological activity and also can be compensated on their activity with each other for elimination of bacterial plaque and anatonical defect.

• Parasites, Hosts and Diseases
• /
• 제54권4호
• /
• pp.519-525
• /
• 2016

To investigate the potential role of transforming growth factor (TGF)-${\beta}1$ in liver fibrosis during Echinococcus granulosus infection, 96 BALB/c mice were randomly divided into 2 groups, experimental group infected by intraperitoneal injection with a metacestode suspension and control group given sterile physiological saline. The liver and blood samples were collected at days 2, 8, 30, 90, 180, and 270 post infection (PI), and the expression of TGF-${\beta}1$ mRNA and protein was determined by real-time quantitative RT-PCR and ELISA, respectively. We also evaluated the pathological changes in the liver during the infection using hematoxylin and eosin (H-E) and Masson staining of the liver sections. Pathological analysis of H-E stained infected liver sections revealed liver cell edema, bile duct proliferation, and structural damages of the liver as evidenced by not clearly visible lobular architecture of the infected liver, degeneration of liver cell vacuoles, and infiltration of lymphocytes at late stages of infection. The liver tissue sections from control mice remained normal. Masson staining showed worsening of liver fibrosis at the end stages of the infection. The levels of TGF-${\beta}1$ did not show significant changes at the early stages of infection, but there were significant increases in the levels of TGF-${\beta}1$ at the middle and late stages of infection (P<0.05). RT-PCR results showed that, when compared with the control group, TGF-${\beta}1$ mRNA was low and comparable with that in control mice at the early stages of infection, and that it was significantly increased at day 30 PI and remained at high levels until day 270 PI (P<0.05). The results of this study suggested that increased expression of TGF-${\beta}1$ during E. granulosus infection may play a significant role in liver fibrosis associated with E. granulosus infection.

• 식물조직배양학회지
• /
• 제21권2호
• /
• pp.85-90
• /
• 1994

기내증식 중인 참나물(Pimpinella brachycarpa)의 엽병을 절편으로하여 체세포배형성을 통한 식물체의 대량증식을 유도하였다. 체세포배 발생은 MS 및 $mB_5$ 기본배지에 BA와 2,4-D, 혹은 BA, 2,4-D 및 NAA를 혼용하여 명배양 하였을때 효과적이었으며, 농도는 BA 0.1 mg/L, 2,4-D 및 NAA는 0.5 mg/L 이었다. 광조건은 식물생창조절 물질의 반응에도 크게 영향을 미쳐, 명배양에서 효과적인 조건이 암배양에서는 전혀 다른 결과를 나타냈다. 즉 MS 및 $mB_5$ 배지에 0.5 mg/L 2,4-D를 각각 첨가하고 명배양한 조건에서는 100%의 체세포배 발생을 보인 반면, 암배양에서는 동일한 배지 조건에서 체세포배가 전혀 형성되지 않았다. 체세포배의 발육단계는 동일한 젤편에서도 많은 차이를 보였으며, 배발생한 캘러스를 $mB_5$ 기본배지 및 0.1 mg/L NAA가 첨가된 배지로 계대배양 하였을때 식물체의 재생에 주효하였다. 이미 형성된 체세포배는 배양기간이 길어지면 캘러스화 되면서 또다른 2차 체세포배가 형성되어 하나의 체세포배로 부터 연속적인 식물체의 재생이 가능하였다. 2,4-D와 NAA의 단독첨가는 캘러스의 형성에는 양호하나 체세포배로부터 식물체의 재생에는 비효과적이었다. NAA를 단독첨가하여 암배양한 절편에서는 2차 계대배양시 절편 표면으로부터 부정근이 형성되었다. 배발생한 캘러스는 BA와 2,4-D가 첨가된 배지에서 약 5주간 간격의 계대배양으로 2년 이상 유지가 가능하였다. 체세포배를 통하여 재생된 식물체는 $mB_5$ 및 MS 기본배지에서 4-6주간 생장시킨 다음, 인공 배양토에서 효과적으로 환경순화 되었다. 이 식물체는 엽병을 절편으로 체세포배 발생을 통한 기내 대량증식이 가능 하다고 사료되었다.

• Journal of Plant Biotechnology
• /
• 제34권1호
• /
• pp.25-29
• /
• 2007

참나리(Lilium lancifolrium)의 접합자배(2n=24)로부터 체세포배발생 및 소자구 형성을 통해 식물체 재분화 체계를 확립하였다. 참나리의 접합자배는 2,4-D가 첨가된 MS 배지에 배양하게되면 소자구 및 체세포배가 동시에 발생하였다. 접합자배로부터 소자구 및 체세포배 형성빈도는 0.1mg/L 2,4-D 첨가 배지에서 각각 66.7% 와 56.7%로 가장 높았다. 그러나 1mg/L 이상의 고농도 2,4-D 처리구에서는 소자구 및 체세포배 형성빈도가 크게 감소하였다. 접합자배에서 형성된 체세포배로부터 식물체를 재생하기 위하여 체세포배를 생장조절제가 첨가되지 않은 MS 기본배지로 옮겨 명배양하였으나 식물체의 발달이 이루어지지 않았으며 신장된 체세포배의 기저부에서 이차적으로 다수의 소자구가 발달하였다. 형성된 소자구를 MS 기본배지로 옮겨 4주간 배양한 결과 정상적인 소식물체로 발달이 이루어졌다. 참나리의 접합자배로부터 직접적인 소자구 형성 및 체세포배로부터 이차적인 소자구 형성을 통해 재생된 식물체는 공히 염색체수가 2n=24 로 2,4-D가 첨가된 배양과정에서 염색체의 안정성이 유지됨을 알 수 있었다.

• Molecules and Cells
• /
• 제40권6호
• /
• pp.386-392
• /
• 2017

Periodontal ligament stem cells (PDLSCs) are multipotent stem cells derived from periodontium and have mesenchymal stem cell (MSC)-like characteristics. Recently, the perivascular region was recognized as the developmental origin of MSCs, which suggests the in vivo angiogenic potential of PDLSCs. In this study, we investigated whether PDLSCs could be a potential source of perivascular cells, which could contribute to in vivo angiogenesis. PDLSCs exhibited typical MSC-like characteristics such as the expression pattern of surface markers (CD29, CD44, CD73, and CD105) and differentiation potentials (osteogenic and adipogenic differentiation). Moreover, PDLSCs expressed perivascular cell markers such as NG2, ${\alpha}-smooth$ muscle actin, platelet-derived growth factor receptor ${\beta}$, and CD146. We conducted an in vivo Matrigel plug assay to confirm the in vivo angiogenic potential of PDLSCs. We could not observe significant vessel-like structures with PDLSCs alone or human umbilical vein endothelial cells (HUVECs) alone at day 7 after injection. However, when PDLSCs and HUVECs were co-injected, there were vessel-like structures containing red blood cells in the lumens, which suggested that anastomosis occurred between newly formed vessels and host circulatory system. To block the $SDF-1{\alpha}$ and CXCR4 axis between PDLSCs and HUVECs, AMD3100, a CXCR4 antagonist, was added into the Matrigel plug. After day 3 and day 7 after injection, there were no significant vessel-like structures. In conclusion, we demonstrated the perivascular characteristics of PDLSCs and their contribution to in vivo angiogenesis, which might imply potential application of PDLSCs into the neovascularization of tissue engineering and vascular diseases.

• Asian Pacific Journal of Cancer Prevention
• /
• 제16권9호
• /
• pp.3595-3604
• /
• 2015

Hepatocellular carcinoma (HCC) has been one of the most fatal malignant tumors worldwide and its associated morbidity and mortality remain of significant concern. Based on in-depth reviews of serological diagnosis of HCC, in addition to AFP, there are other biomarkers: Lens culinaris agglutinin-reactive AFP (AFP-L3), descarboxyprothrombin (DCP), tyrosine kinase with Ig and eprdermal growth factor (EGF) homology domains 2 (TIE2)-espressing monocytes (TEMs), glypican-3 (GPC3), Golgi protein 73 (GP73), interleukin-6 (IL-6), and squamous cell carcinoma antigen (SCCA) have been proposed as biomarkers for the early detection of HCC. The diagnosis of HCC is primarily based on noninvasive standard imaging methods, such as ultrasound (US), dynamic multiphasic multidetector-row CT (MDCT) and magnetic resonance imaging (MRI). Some experts advocate gadolinium diethyl-enetriamine pentaacetic acid (Gd-EOB-DTPA) MRI and contrast-enhanced US as the promising imaging madalities of choice. With regard to recent advancements in tissue markers, many cuting-edge technologies using genome-wide DNA microarrays, qRT-PCR, and proteomic and inmunostaining studies have been implemented in an attempt to identify markers for early diagnosis of HCC. Only less than half of HCC patients at initial diagnosis are at an early stage treatable with curative options: local ablation, surgical resection, or liver transplant. Transarterial chemoembolization (TACE) is considered the standard of care with palliation for intermediate stage HCC. Recent innovative procedures using drug-eluting-beads and radioembolization using Yttrium-90 may exhibit beneficial effects in HCC treatment. During the past few years, several molecular targeted agents have been evaluated in clinical trials in advanced HCC. Sorafenib is currently the only approved systemic treatment for HCC. It has been approved for the therapy of asymptomatic HCC patients with well-preserved liver function who are not candidates for potentially curative treatments, such as surgical resection or liver transplantation. In the USA, Europe and particularly Japan, hepatitis C virus (HCV) related HCC accounts for most liver cancer, as compared with Asia-Pacific regions, where hepatitis B virus (HBV) may play a more important role in HCC development. HBV vaccination, while a vaccine is not yet available against HCV, has been recognized as a best primary prevention method for HBV-related HCC, although in patients already infected with HBV or HCV, secondary prevention with antiviral therapy is still a reasonable strategy. In addition to HBV and HCV, attention should be paid to other relevant HCC risk factors, including nonalcoholic fatty liver disease due to obesity and diabetes, heavy alcohol consumption, and prolonged aflatoxin exposure. Interestingly, coffee and vitamin K2 have been proven to provide protective effects against HCC. Regarding tertiary prevention of HCC recurrence after surgical resection, addition of antiviral treatment has proven to be a rational strategy.